Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03850067
Title A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP

Facility Status City State Zip Country Details
Local Institution - 102 Marseille Cedex 5 13385 France Details
Local Institution - 103 Saint-Herblain 44800 France Details
Local Institution - 100 Villejuif CEDEX 94805 France Details
Local Institution - 203 Ancona 60126 Italy Details
Local Institution - 200 Bologna 40138 Italy Details
Local Institution - 201 Rozzano (MI) 20089 Italy Details
Local Institution - 406 Majadahonda Madrid 28222 Spain Details
Local Institution - 403 Barcelona 08035 Spain Details
Local Institution - 402 Barcelona 08916 Spain Details
Local Institution - 400 Madrid 28041 Spain Details
Local Institution - 404 Malaga 29010 Spain Details
Local Institution - 405 Valencia 46010 Spain Details
Local Institution - 401 Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field